234 related articles for article (PubMed ID: 32743978)
1. Ocular preservation in patients with bilateral retinoblastoma before chemotherapy in situ era: A report from a Mexican Retinoblastoma Reference Hospital.
Del Carmen Bernal-Díaz Z; Murillo-Maldonado MA; Pérez-Villanueva H; Reyes-López A; Ramírez-Ortiz MA
Pediatr Blood Cancer; 2020 Oct; 67(10):e28625. PubMed ID: 32743978
[TBL] [Abstract][Full Text] [Related]
2. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.
Chan MP; Hungerford JL; Kingston JE; Plowman PN
Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
Berry JL; Jubran R; Kim JW; Wong K; Bababeygy SR; Almarzouki H; Lee TC; Murphree AL
Pediatr Blood Cancer; 2013 Apr; 60(4):688-93. PubMed ID: 22997170
[TBL] [Abstract][Full Text] [Related]
4. Long-term visual outcomes in intraocular retinoblastoma with eye preservation.
Batra A; Pushker N; Venkatesh P; Arora T; Tewari R; Bakhshi S
Clin Transl Oncol; 2016 Oct; 18(10):1034-8. PubMed ID: 26781471
[TBL] [Abstract][Full Text] [Related]
5. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part II: Treatment Success and Globe Salvage.
Tomar AS; Finger PT; Gallie B; Mallipatna A; Kivelä TT; Zhang C; Zhao J; Wilson MW; Brenna RC; Burges M; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català J; Correa-Llano G; Carreras E;
Ophthalmology; 2020 Dec; 127(12):1733-1746. PubMed ID: 32526306
[TBL] [Abstract][Full Text] [Related]
6. Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China.
Zhou C; Wen X; Ding Y; Ding J; Jin M; Liu Z; Wang S; Han M; Yuan H; Xiao Y; Wu L; Wang J; Li Y; Yu J; Wen Y; Ye J; Liu R; Chen Z; Xue S; Lu W; Liao H; Cui J; Zhu D; Lu F; Tang S; Wu Y; Yangkyi T; Zhang G; Wubuli M; Guo H; Wang X; He Y; Sheng X; Wang Q; Luo Y; Fan J; Qi J; Yu Z; Tan J; Liang J; Sun X; Jin L; Yang X; Zhang J; Ji X; Zhao J; Jia R; Fan X
Ophthalmology; 2022 Feb; 129(2):209-219. PubMed ID: 34536465
[TBL] [Abstract][Full Text] [Related]
7. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
8. Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma.
Ueda T; Koga Y; Yoshikawa H; Tanabe M; Yamana K; Oba U; Nakashima K; Ono H; Ichimura T; Hasegawa S; Kato W; Kobayashi T; Nakayama H; Sakai Y; Yoshitake T; Ohga S; Oda Y; Suzuki S; Sonoda KH; Ohga S
BMC Pediatr; 2020 Jan; 20(1):37. PubMed ID: 31992242
[TBL] [Abstract][Full Text] [Related]
9. The role of external beam radiation therapy for retinoblastoma after failure of combined chemoreduction and focal consolidation therapy.
Yousef YA; Mohammad M; Jaradat I; Shatnawi R; Banat S; Mehyar M; Al-Nawaiseh I
Ophthalmic Genet; 2020 Feb; 41(1):20-25. PubMed ID: 32072842
[No Abstract] [Full Text] [Related]
10. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
[TBL] [Abstract][Full Text] [Related]
11. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
12. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
[TBL] [Abstract][Full Text] [Related]
13. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
[TBL] [Abstract][Full Text] [Related]
14. Clinical spectrum and treatment outcome of retinoblastoma with Group D and E diseases: A single institution retrospective review.
Weng PY; Chen SH; Kao LY; Tsai YJ; Yang SH; Tseng CK; Tsay PK; Jaing TH
Medicine (Baltimore); 2020 Sep; 99(38):e22201. PubMed ID: 32957352
[TBL] [Abstract][Full Text] [Related]
15. Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma.
Brennan RC; Qaddoumi I; Mao S; Wu J; Billups CA; Stewart CF; Hoehn ME; Rodriguez-Galindo C; Wilson MW
J Clin Oncol; 2017 Jan; 35(1):72-77. PubMed ID: 28034080
[TBL] [Abstract][Full Text] [Related]
16. A retrospective review of visual outcome and complications in the treatment of retinoblastoma.
O'Doherty M; Lanigan B; Breathnach F; O'Meara A; Gallie B; Chan H; O'Keefe M
Ir Med J; 2005 Jan; 98(1):17-20. PubMed ID: 15782728
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma.
Yu X; Li X; Xing Y; Lu S; Tanumiharjo S; Ma J
BMC Cancer; 2020 Aug; 20(1):808. PubMed ID: 32847550
[TBL] [Abstract][Full Text] [Related]
18. The modern role of radiation therapy in treating advanced-stage retinoblastoma: long-term outcomes and racial differences.
Orman A; Koru-Sengul T; Miao F; Markoe A; Panoff JE
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1037-43. PubMed ID: 25442037
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.
Abramson DH; Catalanotti F; Brodie SE; Kellick MG; Francis JH
Ophthalmic Genet; 2018 Jun; 39(3):353-356. PubMed ID: 29513055
[TBL] [Abstract][Full Text] [Related]
20. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]